Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	ACT-541468 5 mg	60
Overall Study	STARTED	ACT-541468 10 mg	59
Overall Study	STARTED	ACT-541468 25 mg	60
Overall Study	STARTED	ACT-541468 50 mg	61
Overall Study	STARTED	Zolpidem	60
Overall Study	STARTED	Placebo	60
Overall Study	COMPLETED	ACT-541468 5 mg	56
Overall Study	COMPLETED	ACT-541468 10 mg	58
Overall Study	COMPLETED	ACT-541468 25 mg	59
Overall Study	COMPLETED	ACT-541468 50 mg	61
Overall Study	COMPLETED	Zolpidem	58
Overall Study	COMPLETED	Placebo	59
Overall Study	NOT COMPLETED	ACT-541468 5 mg	4
Overall Study	NOT COMPLETED	ACT-541468 10 mg	1
Overall Study	NOT COMPLETED	ACT-541468 25 mg	1
Overall Study	NOT COMPLETED	ACT-541468 50 mg	0
Overall Study	NOT COMPLETED	Zolpidem	2
Overall Study	NOT COMPLETED	Placebo	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02839200/flow